Efavirenz
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
<seqtool/> | <seqtool/> | ||
<StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='95/958584/Cv/1'> | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='95/958584/Cv/1'> | ||
| - | Efavirenz (EFV), sold under the brand names Sustiva among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals. It may be used for prevention after a needlestick injury or other potential exposure. It is sold both by itself and in combination as | + | Efavirenz (EFV), sold under the brand names Sustiva among others, is an antiretroviral medication used to treat and prevent HIV/AIDS. It is generally recommended for use with other antiretrovirals. It may be used for prevention after a needlestick injury or other potential exposure. It is sold both by itself and in combination as [[Efavirenz/emtricitabine/tenofovir]]. It is taken by mouth. See also [https://en.wikipedia.org/wiki/Efavirenz]. |
<scene name='95/958584/Cv/3'>Structure of HIV-1 reverse transcriptase initiation complex core with efavirenz</scene> ([[7kjw]]). | <scene name='95/958584/Cv/3'>Structure of HIV-1 reverse transcriptase initiation complex core with efavirenz</scene> ([[7kjw]]). | ||
Revision as of 11:27, 16 January 2024
| |||||||||||
